FDA warning companies not to sell unapproved cannabidiol products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1850卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93810-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[31] The US FDA has sent warning letters to eight manufacturers and 12 distributors to stop manufacturing and distributing unapproved ergotamine
Reactions Weekly, 2007, 1142 (1) : 2 - 2
[32] FDA URGED TO ALLOW SALE OF UNAPPROVED DRUGS
EMBER, L
CHEMICAL & ENGINEERING NEWS, 1995, 73 (03) : 9 - 9
[33] FDA seeks input on unapproved drug issue
Snelson, Harry
JOURNAL OF SWINE HEALTH AND PRODUCTION, 2011, 19 (04): : 249 - 249
[34] FDA REGULATIONS PROVIDE BROADER ACCESS TO UNAPPROVED DRUGS
SHULMAN, SR
RAIFORD, DS
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (07) : 585 - 587
[35] US FDA votes for ban or boxed warning on paracetamol combination products
Reactions Weekly, 2009, 1260 (1) : 2 - 2
[36] Hidden drug ingredients in Umary and Amazy products, warning by US FDA
Reactions Weekly, 2024, 2025 (1) : 3 - 3
[37] Concerns with the use of unapproved products
Snelson, Harry
JOURNAL OF SWINE HEALTH AND PRODUCTION, 2009, 17 (04): : 237 - 237
[38] FDA WARNS MANUFACTURERS, DISTRIBUTORS OF UNAPPROVED ANTIMICROBIALS FOR ANIMALS
Nolen, R. Scott
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2024, 262 (02):
[39] Unapproved drugs - A fix to an unintended consequence of an FDA policy
Novack, Gary D.
OCULAR SURFACE, 2021, 21 : 351 - 354
[40] FDA taking action against unapproved ear drops
Reactions Weekly, 2015, 1560 (1) : 4 - 4

← 1 2 3 4 5 →